These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7659293)

  • 1. Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic region.
    Albers HE; Gillespie CF; Babagbemi TO; Huhman KL
    Neurosci Lett; 1995 May; 191(1-2):63-6. PubMed ID: 7659293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic region.
    Gillespie CF; Huhman KL; Babagbemi TO; Albers HE
    J Biol Rhythms; 1996 Jun; 11(2):137-44. PubMed ID: 8744241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
    Huhman KL; Albers HE
    Peptides; 1994; 15(8):1475-8. PubMed ID: 7700850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase.
    Kallingal GJ; Mintz EM
    Neurosci Lett; 2007 Jul; 422(1):59-63. PubMed ID: 17597298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA(A) and GABA(B) agonists and antagonists alter the phase-shifting effects of light when microinjected into the suprachiasmatic region.
    Gillespie CF; Mintz EM; Marvel CL; Huhman KL; Albers HE
    Brain Res; 1997 Jun; 759(2):181-9. PubMed ID: 9221935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides phase shift the mammalian circadian pacemaker.
    Piggins HD; Antle MC; Rusak B
    J Neurosci; 1995 Aug; 15(8):5612-22. PubMed ID: 7643205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of colocalized neuropeptides: functional significance in the circadian timing system.
    Albers HE; Liou SY; Stopa EG; Zoeller RT
    J Neurosci; 1991 Mar; 11(3):846-51. PubMed ID: 2002363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2006 Nov; 24(10):2853-8. PubMed ID: 17156209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An NMDA antagonist inhibits light but not GRP-induced phase shifts when administered after the phase-shifting stimulus.
    Kallingal GJ; Mintz EM
    Brain Res; 2010 Sep; 1353():106-12. PubMed ID: 20682305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2014 Feb; 39(4):630-9. PubMed ID: 24528136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro.
    McArthur AJ; Coogan AN; Ajpru S; Sugden D; Biello SM; Piggins HD
    J Neurosci; 2000 Jul; 20(14):5496-502. PubMed ID: 10884333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in colocalization between Fos and PHI, GRP, VIP and VP in neurons of the rat suprachiasmatic nucleus after a light stimulus during the phase delay versus the phase advance period of the night.
    Romijn HJ; Sluiter AA; Pool CW; Wortel J; Buijs RM
    J Comp Neurol; 1996 Aug; 372(1):1-8. PubMed ID: 8841917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-releasing peptide induces c-Fos in the hamster suprachiasmatic nucleus.
    Piggins HD; Goguen D; Rusak B
    Neurosci Lett; 2005 Aug; 384(3):205-10. PubMed ID: 15955628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of damage to SCN neurons and efferent pathways on circadian activity rhythms of hamsters.
    Harrington ME; Rahmani T; Lee CA
    Brain Res Bull; 1993; 30(5-6):655-69. PubMed ID: 8457913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photic regulation of peptides located in the ventrolateral subdivision of the suprachiasmatic nucleus of the rat: daily variations of vasoactive intestinal polypeptide, gastrin-releasing peptide, and neuropeptide Y.
    Shinohara K; Tominaga K; Isobe Y; Inouye ST
    J Neurosci; 1993 Feb; 13(2):793-800. PubMed ID: 8426236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase shifts to light are altered by antagonists to neuropeptide receptors.
    Chan RK; Sterniczuk R; Enkhbold Y; Jeffers RT; Basu P; Duong B; Chow SL; Smith VM; Antle MC
    Neuroscience; 2016 Jul; 327():115-24. PubMed ID: 27090819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.
    Duncan MJ; Hester JM; Hopper JA; Franklin KM
    Eur J Neurosci; 2010 May; 31(9):1646-54. PubMed ID: 20525077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
    Huhman KL; Gillespie CF; Marvel CL; Albers HE
    Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian locomotor rhythms, but not photoperiodic responses, survive surgical isolation of the SCN in hamsters.
    Hakim H; DeBernardo AP; Silver R
    J Biol Rhythms; 1991; 6(2):97-113. PubMed ID: 1773090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase delays to light and gastrin-releasing peptide require the protein kinase A pathway.
    Sterniczuk R; Yamakawa GR; Pomeroy T; Antle MC
    Neurosci Lett; 2014 Jan; 559():24-9. PubMed ID: 24287375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.